When did STANDARD BIOTOOLS INC (LAB) report earnings last quarter?
STANDARD BIOTOOLS INC (LAB) last reported earnings on 2/24/2026.
STANDARD BIOTOOLS INC (LAB) Earnings History & Surprises
NASDAQ:LAB • US34385P1084
Current stock price
0.9079 USD
-0.01 (-1.13%)
At close:
0.9079 USD
0 (0%)
After Hours:
LAB Earnings overview
Past quarterly earnings results for STANDARD BIOTOOLS INC (LAB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.05
- Revenue Estimate
- 17.992M
Last Reported
Most Recent- Release Date
- Feb 24, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.05
- EPS Surprise
- 170.72%
- Revenue Surprise
- 27.33%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.05 | -0.07 | 170.72% | 155.56% | 23.795M | 18.687M | 27.33% | -49.07% |
| Q3 2025 | -0.09 | -0.06 | -62.02% | -28.57% | 19.552M | 18.178M | 7.56% | -56.52% |
| Q2 2025 | -0.09 | -0.08 | -11.39% | 25.00% | 41.962M | 40.222M | 4.33% | 12.79% |
| Q1 2025 | -0.07 | -0.08 | 7.59% | 74.07% | 40.795M | 40.501M | 0.73% | -10.42% |
| Q4 2024 | -0.09 | -0.07 | -27.30% | 64.00% | 46.718M | 43.464M | 7.49% | 65.74% |
| Q3 2024 | -0.07 | -0.09 | 22.99% | 74.07% | 44.969M | 41.408M | 8.60% | 77.27% |
| Q2 2024 | -0.12 | -0.09 | -39.78% | 45.45% | 37.205M | 48.733M | -23.66% | 35.36% |
| Q1 2024 | -0.27 | -0.11 | -135.88% | -145.45% | 45.54M | 46.466M | -1.99% | 81.29% |
| Q4 2023 | -0.25 | -0.13 | -90.40% | -31.58% | 28.188M | 25.149M | 12.08% | 4.32% |
| Q3 2023 | -0.27 | -0.12 | -122.77% | -3.85% | 25.367M | 23.836M | 6.42% | -1.10% |
| Q2 2023 | -0.22 | -0.21 | -3.72% | 33.33% | 27.486M | 24.442M | 12.45% | 46.36% |
| Q1 2023 | -0.11 | - | 56.00% | 25.12M | - | -5.21% | ||
| Q4 2022 | -0.19 | - | -58.33% | 27.02M | - | -29.40% | ||
| Q3 2022 | -0.26 | - | -44.44% | 25.65M | - | -10.00% | ||
| Q2 2022 | -0.33 | - | -43.48% | 18.78M | - | -39.46% | ||
| Q1 2022 | -0.25 | - | - | 26.5M | - | -19.18% | ||
| Q4 2021 | -0.12 | -0.28 | 57.57% | 50.00% | 38.27M | 33.027M | 15.87% | -14.21% |
| Q3 2021 | -0.18 | -0.22 | 18.99% | -125.00% | 28.5M | 30.3M | -5.94% | -28.50% |
| Q2 2021 | -0.23 | -0.20 | -16.78% | -27.78% | 31.02M | 31.326M | -0.98% | 19.03% |
| Q1 2021 | -0.25 | -0.14 | -72.70% | -8.70% | 32.79M | 32.291M | 1.55% | 18.72% |
| Q4 2020 | -0.24 | -0.07 | -256.42% | - | 44.61M | 51.227M | -12.92% | - |
| Q3 2020 | -0.08 | -0.20 | 60.40% | - | 39.86M | 32.783M | 21.59% | - |
| Q2 2020 | -0.18 | -0.23 | 22.51% | - | 26.06M | 19.261M | 35.30% | - |
| Q1 2020 | -0.23 | -0.15 | -51.82% | - | 27.62M | 29.32M | -5.80% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
26.23%
Max EPS beat (4)
170.72%
Min EPS beat (4)
-62.02%
Revenue beat statistics
Revenue beat (4)
4
Average Revenue beat (4)
9.99%
Max Revenue beat (4)
27.33%
Min Revenue beat (4)
0.73%
Analysis
In the last 4 quarters, LAB has beaten EPS estimates in 2 out of 4 releases
LAB has consistently beaten revenue estimates in all past 4 earnings releases
In the last 4 quarters, LAB has beaten the EPS estimates by 26.2% on average.
In the last 4 quarters, LAB has beaten the revenue estimates by 10.0% on average.
Related analysis
STANDARD BIOTOOLS INC / LAB Earnings FAQ
Did STANDARD BIOTOOLS INC (LAB) beat earnings estimates last quarter?
STANDARD BIOTOOLS INC (LAB) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does LAB stock beat earnings estimates?
In the last 4 quarters, STANDARD BIOTOOLS INC (LAB) has beaten EPS estimates in 2 out of 4 releases.